24
Participants
Start Date
January 31, 2009
Primary Completion Date
February 28, 2009
Study Completion Date
February 28, 2009
Metformin
225 mg q12, oral PD 0332334 immediate release formulation on Days 1 through 5; Single, oral, 500 mg dose of metformin immediate release
Metformin
Single, oral, 500 mg of metformin immediate release
PD 0332334
500 mg q12, oral metformin immediate release administered on Days 1 through Day 6 Single, oral, 300 mg dose of PD 0332334 immediate release formulation administered on Day 3
PD 0332334
Single, oral, 300 mg dose of PD 0332334 immediate release formulation
Pfizer Investigational Site, Singapore
Lead Sponsor
Pfizer
INDUSTRY